We’re excited to announce we will be attending PEGS Boston 2025, the premier industry summit for biologics and protein engineering! From May 12-16, 2025, leading scientists, innovators, and decision-makers will gather in Boston, MA, to explore the latest advancements in drug development, immunotherapy, radiotherapy, and AI-driven biologics research. With 350+ speakers, 120+ exhibitors, and 2,400 participants, PEGS Boston is the must-attend event for cutting-edge collaboration and discovery.
Join us at our booth to learn how our revolutionary picodroplet microfluidic technology is transforming single-cell analysis and isolation. Whether you’re working in antibody discovery, protein engineering, or cell therapy, our high-throughput solutions empower researchers to identify and isolate the most valuable cells with precision and efficiency.
Planning to attend? Let’s connect! Book a meeting with our team to discover how we can accelerate your biologics research and streamline your workflows.
SPEAKER PRESENTATION
11.25am
Richard Hammond
Chief Technical Officer
Sphere Bio
Abstract
Development of CAR-T therapies relies on two core processes: high-efficiency gene editing and selection of edited cells with the required functional capabilities from a population. In this talk we will introduce Cyto-Mine® Chroma, a novel platform for assessing cell function and selecting high-performing cells quickly and easily. We will also introduce a new Cyto-Mine® upgrade module in development to allow high-throughput gene editing workflows and cell-cell functional interaction studies.
Benjamin Duckless
Senior Field Application Scientist
Sphere Bio
POSTER PRESENTATION
4:00 – 4:40pm
Wednesday, May 14
9:35 – 10:20am
4:00 – 4:40pm
6:40 – 7:40pm
